Cholesterol-dependent molecular mechanisms contribute to cationic amphiphilic drugs’ prevention of silica-induced inflammation
Open Access
- 13 March 2023
- journal article
- research article
- Published by Elsevier in European Journal of Cell Biology
- Vol. 102 (2) , 151310
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (P30GM103338)
- National Institute of Environmental Health Sciences (F31ES033562, R01ES033533)
This publication has 50 references indexed in Scilit:
- Cationic Amphiphilic Drugs Cause a Marked Expansion of Apparent Lysosomal Volume: Implications for an Intracellular Distribution-Based Drug InteractionMolecular Pharmaceutics, 2012
- Analysis of Cholesterol Trafficking with Fluorescent Probes2012
- Attenuation of the Lysosomal Death Pathway by Lysosomal Cholesterol AccumulationThe American Journal of Pathology, 2011
- Nonesterified cholesterol content of lysosomes modulates susceptibility to oxidant-induced permeabilizationFree Radical Biology and Medicine, 2011
- Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusionJournal of Lipid Research, 2010
- Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cellsProceedings of the National Academy of Sciences, 2010
- NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomesProceedings of the National Academy of Sciences, 2008
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- The IL-4Rα pathway in macrophages and its potential role in silica-induced pulmonary fibrosisJournal of Leukocyte Biology, 2007
- Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C diseaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990